Literature DB >> 21510237

Beneficial effects of fluvoxamine for hemiballism in a patient with depressive disorder: a case report.

Ali Cayköylü1, Yakup Albayrak, Görkem Karakaş Uğurlu, Okan Ekinci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21510237

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN： 0300-9009            Impact factor:   2.396


× No keyword cloud information.
  4 in total

1.  Beneficial Effects of Fluvoxamine for Chorea in a Patient With Huntington's Disease: A Case Report.

Authors:  Yakup Albayrak; Görkem Karakas Uğurlu; Mustafa Uğurlu; Ali Cayköylü
Journal:  Prim Care Companion CNS Disord       Date:  2012

2.  Beneficial effects of the sigma-1 agonist fluvoxamine for tardive dyskinesia in patients with postpsychotic depressive disorder of schizophrenia: report of 5 cases.

Authors:  Yakup Albayrak; Kenji Hashimoto
Journal:  Prim Care Companion CNS Disord       Date:  2012-11-08

3.  A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine.

Authors:  Yakup Albayrak; Murat Beyazyüz; Özlem Abbak; Ece Altındağ
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-02-28       Impact factor: 2.582

4.  Benefical effects of sigma-1 agonist fluvoxamine for tardive dyskinesia and tardive akathisia in patients with schizophrenia: report of three cases.

Authors:  Yakup Albayrak; Kenji Hashimoto
Journal:  Psychiatry Investig       Date:  2013-10-24       Impact factor: 2.505
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.